ConductScience.org, home

Paper23970967

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Aliyu G and 9 others. Tuberc Res Treat, 2013. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria. Papers, record 23970967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23970967

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.
PubMed
Journal
Tuberc Res Treat
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2022-03-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aliyu GGambo
2El-Kamary SSSamer S
3Abimiku AAlash'le
4Ezati NNicholas
5Mosunmola IIwakun
6Hungerford LLaura
7Brown CClayton
8Tracy KJKathleen J
9Obasanya JJoshua
10Blattner WWilliam

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
D43 TW001041FIC NIH HHSUnited StatesD43TW001041PubMed

Source NIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110325347Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa.J Clin Microbiol1999https://conductscience.org/library/papers/10325347PubMed
212791901Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates.J Clin Microbiol2003https://conductscience.org/library/papers/12791901PubMed
321127999Drug-resistant tuberculosis: an insurmountable epidemic?Inflammopharmacology2011https://conductscience.org/library/papers/21127999PubMed
417496986Human pulmonary infections with bovine and environment (atypical) mycobacteria in jos, Nigeria.Ghana Med J2006https://conductscience.org/library/papers/17496986PubMed
521564425Resistance to first-line tuberculosis drugs in three cities of Nigeria.Trop Med Int Health2011https://conductscience.org/library/papers/21564425PubMed
615780329The trend of pulmonary tuberculosis in patients seen at DOTS clinics in the Federal Capital Territory, Abuja, Nigeria.Public Health2005https://conductscience.org/library/papers/15780329PubMed
78630625Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis.Am J Respir Crit Care Med1996https://conductscience.org/library/papers/8630625PubMed
822257494Spoligotyping of Mycobacterium africanum, Burkina Faso.Emerg Infect Dis2012https://conductscience.org/library/papers/22257494PubMed
911463226Mycobacterium bovis infection in human beings.Tuberculosis (Edinb)2001https://conductscience.org/library/papers/11463226PubMed
1021771441Prevalence and risk factors associated with drug resistant TB in South West, Nigeria.Asian Pac J Trop Med2011https://conductscience.org/library/papers/21771441PubMed
1117172361Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.Am J Trop Med Hyg2006https://conductscience.org/library/papers/17172361PubMed
12214929266-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.Lancet2011https://conductscience.org/library/papers/21492926PubMed
1312200527A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK.Thorax2002https://conductscience.org/library/papers/12200527PubMed
1419421759Lower gastrointestinal tract tuberculosis: an important but neglected disease.Int J Colorectal Dis2009https://conductscience.org/library/papers/19421759PubMed
1518436594
Evaluation of the GenoType Mycobacteria Direct assay for the simultaneous detection of the Mycobacterium tuberculosis complex and four atypical mycobacterial species in smear-positive respiratory specimens.
J Med Microbiol2008https://conductscience.org/library/papers/18436594PubMed
1620487550Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.BMC Infect Dis2010https://conductscience.org/library/papers/20487550PubMed
1715260279Contact investigation for cases of pulmonary Mycobacterium bovis.Int J Tuberc Lung Dis2004https://conductscience.org/library/papers/15260279PubMed
1821361110WHO global tuberculosis control report 2010. Summary.Cent Eur J Public Health2010https://conductscience.org/library/papers/21361110PubMed
1916390943Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria.J Clin Microbiol2006https://conductscience.org/library/papers/16390943PubMed
2020678329Novel Mycobacterium tuberculosis complex pathogen, M. mungi.Emerg Infect Dis2010https://conductscience.org/library/papers/20678329PubMed

See all 40 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
41877055
Magnitude of Tuberculosis, drug resistance patterns and associated factors among presumptive TB patients at five selected public Hospitals, Somali Region, Eastern Ethiopia. Retrospective cross-sectional study.
BMC Infect Dis2026https://conductscience.org/library/papers/41877055PubMed
36209340Prevalence and Retrospective Insight on Tuberculosis in Human Patients in Cross River State, Nigeria; One Health Approach to its Control.Curr Microbiol2022https://conductscience.org/library/papers/36209340PubMed
36186793Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil.Front Med (Lausanne)2022https://conductscience.org/library/papers/36186793PubMed
33884358INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA.Afr J Infect Dis2021https://conductscience.org/library/papers/33884358PubMed
33116664Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia.Infect Drug Resist2020https://conductscience.org/library/papers/33116664PubMed
31720393Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia.J Clin Tuberc Other Mycobact Dis2018https://conductscience.org/library/papers/31720393PubMed
30319278Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria.Infect Drug Resist2018https://conductscience.org/library/papers/30319278PubMed
30192746Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.PLoS One2018https://conductscience.org/library/papers/30192746PubMed
28945771Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One2017https://conductscience.org/library/papers/28945771PubMed
28879163Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges.Afr J Lab Med2017https://conductscience.org/library/papers/28879163PubMed
28704459Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis.PLoS One2017https://conductscience.org/library/papers/28704459PubMed
28057041
Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.
BMC Res Notes2017https://conductscience.org/library/papers/28057041PubMed
25495355Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.BMC Infect Dis2014https://conductscience.org/library/papers/25495355PubMed
24622091Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa.J Clin Microbiol2014https://conductscience.org/library/papers/24622091PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23970967

GET https://conductscience.org/api/papers/v1/23970967/references?page=2